| 张晶晶,周家军,孟祥云,等.门诊处方前置审核模式上线后的实践与评价[J].安徽医药,2025,29(10):2112-2116. |
| 门诊处方前置审核模式上线后的实践与评价 |
| Practice and evaluation of the pre-prescription review mode for outpatient prescriptions after its launch |
| |
| DOI：10.3969/j.issn.1009-6469.2025.10.040 |
| 中文关键词: 处方审核 药物疗法，计算机辅助 处方不当 处方前置审核 实践模式 效果评价 合理用药 改进措施 |
| 英文关键词: Prescription review Drug therapy,computer-assisted Inappropriate prescribing Prescription pre-approval Practi-cal mode Effect evaluation Rational use Improvement measures |
| 基金项目:重大新药创制科技重大专项( 2020ZX09201-004)；中国药学会医院药学专委会医院药学科研专项资助项目(CPA-Z05-ZC-2021-002)；高等学校省级质量工程项目( 2021jyxm1799) |
|
| 摘要点击次数: 48 |
| 全文下载次数: 67 |
| 中文摘要: |
| 目的探讨门诊处方前置审核的实施效果，持续优化该模式以促进合理用药。方法收集 2023年 1—12月合肥市第二人民医院门诊处方前置审核系统平台数据，统计分析处方合理率、任务合格率等指标变化情况。结果门诊处方前置审核模式上线后， 2023年 1—6月与 2023年 7—12月的数据对比，审核系统处方合理率从 85.44%上升到 91.15%(χ2=3 781.02，P<0.001)任务合格率从 95.89%上升为 96.55%(χ2=140.66，P<0.001)药师审核率从 4.17%下降为 0.94%(χ2=5 323.02，P<0.001)，药审方师干预率从 16.38%上升到 28.16%(χ2=461.81，P<0.001)，医师修改处方率从 53.17%上升到 70.87%(χ2=392.61，P<0.001)。2023年 1—6月的信号灯警示次数、警示比例对比 2023年 7—12月的数据，差异有统计学意义。绘制门诊处方问题类型帕累托图，其中超适应证用药、超多日用量为处方不合理的主要因素，剂量范围不适宜为处方不合理的次要因素。结论门诊处方前置审核模式，促进了药师与医师的沟通，提高临床合理用药水平，保障病人用药安全。 |
| 英文摘要: |
| Objective To explore the implementation and effectiveness of pre-prescription review of outpatient prescriptions, and to continuously optimize this model to promote rational drug use.Methods We collected data from the outpatient pre-prescription reviewplatform of Hefei Second People's Hospital from January to December 2023, and analyzed the changes in indicators such as prescrip-tion rationality rate and task qualification rate.Results After the launch of the pre-prescription review mode for outpatients, the com-parison between data from January to June 2023 and those from July to December 2023 showed that the prescription rationality rate in-creased from 85.44% to 91.15% (χ2=3 781.02, P<0.001), the task qualification rate increased from 95.89% to 96.55% (χ2=140.66, P< 0.001), the pharmacist review rate decreased from 4.17% to 0.94% (χ2=5 323.02, P<0.001), the pharmacist intervention rate increased from 16.38% to 28.16% (χ2=461.81, P<0.001), and the prescription modification rate by physicians increased from 53.17% to 70.87% (χ2=392.61, P<0.001). The number and proportion of signal light warnings from January to June 2023 were compared with the datafrom July to December 2023, and the difference was statistically significant. A Pareto diagram of outpatient prescription problem typeswas drawn, where over indication medication and excessive daily dosage were the main factors causing irrational prescriptions, and in-appropriate dosage range was the secondary factor.Conclusion The pre-prescription review mode for outpatients promotes the commu-nication between pharmacists and physicians, improves the level of rational clinical medication, and ensures the safety of patient medi-cation. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
